Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Pain Self-Management for Veterans: Development and Pilot Test of a Stage-Based Mobile-Optimized Intervention.

Johnson SS, Levesque DA, Broderick LE, Bailey DG, Kerns RD.

JMIR Med Inform. 2017 Oct 17;5(4):e40. doi: 10.2196/medinform.7117.

2.

Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinically.

Dresser GK, Urquhart BL, Proniuk J, Tieu A, Freeman DJ, Arnold JM, Bailey DG.

Pharmacol Res Perspect. 2017 Oct;5(5). doi: 10.1002/prp2.346.

3.

Efficient Hardware Implementation For Fingerprint Image Enhancement Using Anisotropic Gaussian Filter.

Khan TM, Bailey DG, Khan MAU, Kong Y.

IEEE Trans Image Process. 2017 May;26(5):2116-2126. doi: 10.1109/TIP.2017.2671781. Epub 2017 Feb 20.

PMID:
28237927
4.

Carboxyhemoglobin - the forgotten parameter of neonatal hyperbilirubinemia.

Bailey DGN, Fuchs H, Hentschel R.

J Perinat Med. 2017 Jul 26;45(5):613-617. doi: 10.1515/jpm-2016-0053.

PMID:
28099134
5.

Better to Avoid Grapefruit with Certain Statins.

Bailey DG.

Am J Med. 2016 Nov;129(11):e301. doi: 10.1016/j.amjmed.2016.05.038. No abstract available.

PMID:
27770845
6.

Predicting clinical relevance of grapefruit-drug interactions: a complicated process.

Bailey DG.

J Clin Pharm Ther. 2017 Apr;42(2):125-127. doi: 10.1111/jcpt.12463. Epub 2016 Oct 6.

PMID:
27709656
7.

Coffee-Antihypertensive Drug Interaction: A Hemodynamic and Pharmacokinetic Study With Felodipine.

Bailey DG, Dresser GK, Urquhart BL, Freeman DJ, Arnold JM.

Am J Hypertens. 2016 Dec 1;29(12):1386-1393. doi: 10.1093/ajh/hpw081.

PMID:
27481881
8.

Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.

Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, Shariff SZ, Gomes T, Mamdani M, Gandhi S, Dixon S, Garg AX.

CMAJ. 2015 Feb 17;187(3):174-180. doi: 10.1503/cmaj.140950. Epub 2014 Dec 22.

9.

Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury.

Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX.

JAMA. 2013 Dec 18;310(23):2544-53. doi: 10.1001/jama.2013.282426.

PMID:
24346990
10.

Grapefruit juice and clopidogrel.

Bailey DG.

CMAJ. 2013 Sep 3;185(12):1066. doi: 10.1503/cmaj.113-2127. No abstract available.

11.

Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.

Fleet JL, Shariff SZ, Bailey DG, Gandhi S, Juurlink DN, Nash DM, Mamdani M, Gomes T, Patel AM, Garg AX.

BMJ Open. 2013 Jul 11;3(7). pii: e002857. doi: 10.1136/bmjopen-2013-002857. Print 2013.

12.

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.

Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX.

Ann Intern Med. 2013 Jun 18;158(12):869-76. doi: 10.7326/0003-4819-158-12-201306180-00004.

PMID:
23778904
13.

Grapefruit-medication interactions.

Bailey DG.

CMAJ. 2013 Apr 2;185(6):507-8. doi: 10.1503/cmaj.113-2110. No abstract available.

14.

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Bailey DG, Dresser G, Arnold JM.

CMAJ. 2013 Mar 5;185(4):309-16. doi: 10.1503/cmaj.120951. Epub 2012 Nov 26. Review. No abstract available.

15.

Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Bailey DG.

Br J Clin Pharmacol. 2010 Nov;70(5):645-55. doi: 10.1111/j.1365-2125.2010.03722.x. Review.

16.

Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.

Asanuma Y, Oeser A, Stanley E, Bailey DG, Shintani A, Stein CM.

Arch Drug Inf. 2008 Jul;1(1):14-22.

17.

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.

Ho RH, Choi L, Lee W, Mayo G, Schwarz UI, Tirona RG, Bailey DG, Stein CM, Kim RB.

Pharmacogenet Genomics. 2007 Aug;17(8):647-56.

18.

Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.

Bailey DG, Dresser GK, Leake BF, Kim RB.

Clin Pharmacol Ther. 2007 Apr;81(4):495-502. Epub 2007 Feb 14.

PMID:
17301733
19.

Intestinal drug transporter expression and the impact of grapefruit juice in humans.

Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.

Clin Pharmacol Ther. 2007 Mar;81(3):362-70. Epub 2007 Jan 10.

PMID:
17215845
20.

Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition.

Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A.

Br J Clin Pharmacol. 2006 Oct;62(4):485-91.

21.

Herbal product-drug interactions mediated by induction.

Tirona RG, Bailey DG.

Br J Clin Pharmacol. 2006 Jun;61(6):677-81.

22.

Grapefruit juice ingestion significantly reduces talinolol bioavailability.

Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB, Bailey DG, Kirch W.

Clin Pharmacol Ther. 2005 Apr;77(4):291-301.

PMID:
15903127
23.

Sun drop citrus soda and cyclosporine interaction: comments on causality and recommendations.

Bailey DG.

Transplantation. 2005 Mar 27;79(6):747. No abstract available.

PMID:
15785395
24.
25.

Grapefruit juice-drug interactions. 1998.

Bailey DG, Malcolm J, Arnold O, Spence JD.

Br J Clin Pharmacol. 2004 Dec;58(7):S831-40; discussion S841-3. No abstract available.

26.

Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans.

Goosen TC, Cillié D, Bailey DG, Yu C, He K, Hollenberg PF, Woster PM, Cohen L, Williams JA, Rheeders M, Dijkstra HP.

Clin Pharmacol Ther. 2004 Dec;76(6):607-17.

27.

Interactions between grapefruit juice and cardiovascular drugs.

Bailey DG, Dresser GK.

Am J Cardiovasc Drugs. 2004;4(5):281-97. Review.

PMID:
15449971
28.

Natural products and adverse drug interactions.

Bailey DG, Dresser GK.

CMAJ. 2004 May 11;170(10):1531-2. No abstract available.

29.

The effects of fruit juices on drug disposition: a new model for drug interactions.

Dresser GK, Bailey DG.

Eur J Clin Invest. 2003 Nov;33 Suppl 2:10-6. Review.

PMID:
14641551
30.

The effects of treating bovine hide with steam at subatmospheric pressure on bacterial numbers and leather quality.

McEvoy JM, Doherty AM, Sheridan JJ, Bailey DG, Blair IS, McDowell DA.

Lett Appl Microbiol. 2003;37(4):344-8.

31.

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.

Bailey DG, Dresser GK, Bend JR.

Clin Pharmacol Ther. 2003 Jun;73(6):529-37.

PMID:
12811362
32.

A basic conceptual and practical overview of interactions with highly prescribed drugs.

Dresser GK, Bailey DG.

Can J Clin Pharmacol. 2002 Winter;9(4):191-8. Review.

PMID:
12584577
33.

Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.

Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG.

Clin Pharmacol Ther. 2002 Sep;72(3):247-55.

PMID:
12235445
34.

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.

Clin Pharmacol Ther. 2002 Jan;71(1):11-20.

PMID:
11823753
35.

Red wine-cisapride interaction: comparison with grapefruit juice.

Offman EM, Freeman DJ, Dresser GK, Munoz C, Bend JR, Bailey DG.

Clin Pharmacol Ther. 2001 Jul;70(1):17-23.

PMID:
11452240
36.

Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.

Malhotra S, Bailey DG, Paine MF, Watkins PB.

Clin Pharmacol Ther. 2001 Jan;69(1):14-23.

37.

Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.

Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR.

Clin Pharmacol Ther. 2000 Nov;68(5):468-77.

PMID:
11103749
38.

Grapefruit juice--felodipine interaction in the elderly.

Dresser GK, Bailey DG, Carruthers SG.

Clin Pharmacol Ther. 2000 Jul;68(1):28-34.

PMID:
10945313
39.

Grapefruit juice-lovastatin interaction.

Bailey DG, Dresser GK.

Clin Pharmacol Ther. 2000 Jun;67(6):690. No abstract available.

PMID:
10872652
40.

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Dresser GK, Spence JD, Bailey DG.

Clin Pharmacokinet. 2000 Jan;38(1):41-57. Review.

PMID:
10668858
41.

Molecular and physical mechanisms of first-pass extraction.

Hall SD, Thummel KE, Watkins PB, Lown KS, Benet LZ, Paine MF, Mayo RR, Turgeon DK, Bailey DG, Fontana RJ, Wrighton SA.

Drug Metab Dispos. 1999 Feb;27(2):161-6. Review.

PMID:
9929497
42.

Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans.

Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR.

Clin Pharmacol Ther. 1998 Sep;64(3):248-56.

PMID:
9757148
43.

Grapefruit juice-drug interactions.

Bailey DG, Malcolm J, Arnold O, Spence JD.

Br J Clin Pharmacol. 1998 Aug;46(2):101-10. Review.

44.

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB.

J Clin Invest. 1997 May 15;99(10):2545-53.

45.

Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance.

Rau SE, Bend JR, Arnold MO, Tran LT, Spence JD, Bailey DG.

Clin Pharmacol Ther. 1997 Apr;61(4):401-9.

PMID:
9129557
46.

Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice.

Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD.

Clin Pharmacol Ther. 1996 Jul;60(1):25-33.

PMID:
8689808
47.

Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.

Bailey DG, Arnold JM, Bend JR, Tran LT, Spence JD.

Br J Clin Pharmacol. 1995 Aug;40(2):135-40.

48.

The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.

Clement JG, Bailey DG, Madill HD, Tran LT, Spence JD.

Biopharm Drug Dispos. 1995 Jul;16(5):415-25.

PMID:
8527690
49.

Grapefruit juice and drugs. How significant is the interaction?

Bailey DG, Arnold JM, Spence JD.

Clin Pharmacokinet. 1994 Feb;26(2):91-8. Review. No abstract available.

PMID:
8162660
50.

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.

Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD.

Clin Pharmacol Ther. 1993 Dec;54(6):589-94.

PMID:
8275614

Supplemental Content

Loading ...
Support Center